ViiV's Dovato Matches Gilead's Biktarvy in Clinical Trial

A head-to-head clinical trial has demonstrated that ViiV Healthcare's Dovato is as effective as Gilead Sciences' Biktarvy, indicating comparable efficacy between the two treatments.